Marinus Pharmaceuticals (MRNS)
(Delayed Data from NSDQ)
$1.30 USD
-0.02 (-1.52%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -0.60 |
Last EPS Surprise | -1.69% |
ABR | 1.60 |
Earnings ESP
|
-0.19% |
---|---|
Current Year | -1.88 |
Next Year | -0.91 |
EPS (TTM) | -2.63 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.89M | 11.95M | 36.55M | 56.04M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 9.50M | 19.40M | 43.80M | 86.33M |
Low Estimate | 8.61M | 9.47M | 33.81M | 44.40M |
Year ago Sales | 7.34M | 7.19M | 30.99M | 36.55M |
Year over Year Growth Est. | 21.09% | 66.13% | 17.95% | 53.31% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -0.24 | -1.88 | -0.91 |
# of Estimates | 6 | 5 | 7 | 6 |
Most Recent Consensus | -0.47 | -0.25 | -1.88 | -1.10 |
High Estimate | -0.40 | -0.12 | -1.34 | -0.48 |
Low Estimate | -0.49 | -0.41 | -2.21 | -1.43 |
Year ago EPS | -0.61 | -0.74 | -2.63 | -1.88 |
Year over Year Growth Est. | 26.23% | 67.57% | 28.52% | 51.75% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 3 | 3 | 3 |
Up Last 60 Days | 1 | 3 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 3 | 2 |
Down Last 60 Days | 2 | 2 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -0.24 | -1.88 | -0.91 |
7 Days Ago | -0.45 | -0.24 | -1.86 | -0.82 |
30 Days Ago | -0.42 | -0.24 | -1.87 | -0.90 |
60 Days Ago | -0.42 | -0.24 | -1.87 | -0.90 |
90 Days Ago | -0.42 | -0.24 | -1.87 | -0.90 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.24 | -1.85 | -0.87 |
Zacks Consensus Estimate | -0.45 | -0.24 | -1.88 | -0.91 |
Earnings ESP | -0.19% | 0.00% | 1.92% | 4.18% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.60 | -0.68 | -0.74 | -0.61 | NA |
Estimate | -0.59 | -0.68 | -0.64 | -0.67 | NA |
Difference | -0.01 | 0.00 | -0.10 | 0.06 | -0.01 |
Surprise | -1.69% | 0.00% | -15.63% | 8.96% | -2.09% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more